Therefore, the effect of AT1R-AAs may be related to a type II hypersensitivity response, similar to autobodies of thyroid-stimulating hormone receptor (TSHR) that can overactivate TSHR in Graves’ disease [36]. This evidence concerns the gene TSHR and Graves disease.